24/7 Support Number +91-9137-44-1392

Dr Jay Mehta

Dr. Jay Mehta

Dr. Jay Mehta, President & Head of Neuberg Oncopath, is a distinguished surgical pathologist specializing in Oncopathology. Having completed his post-graduation at Tata Memorial Hospital, Mumbai, he possesses two decades of extensive experience in the field. Dr. Mehta’s expertise lies in diagnosing and analyzing cancerous tissues, contributing significantly to the field of Oncopathology. His leadership at Neuberg Oncopath underscores his commitment to providing high-quality diagnostic services in oncology.

Careers

  • Anatomic and Molecular Pathologist – Neuberg Diagnostics, 2022-Present
  • Anatomic & Molecular Pathologist – Tata Trusts, 2019-2022
  • Consultant Pathologist at the Centre of Excellence in Histopathology – SRL Diagnostics, 2004-2019

Treatments

Dr. Jay Mehta specializes in the following treatments –

Publications

Dr. Jay Mehta has many National and International papers and Publications. Some of the few includes –

Revised Myeloproliferative Neoplasms Working Group Consensus Recommendations for Diagnosis and Management of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocythemia

Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia

Revised Myeloproliferative Neoplasms Working Group Consensus Recommendations for Diagnosis and Management of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocythemia

Dr. Jay Mehta stands as a pioneer in diagnostic molecular pathology in India, conducting diverse molecular tests, including next-generation sequencing, for both solid and liquid tumors. As the first Indian pathologist to initiate PDL1 testing, he demonstrates a keen focus on biomarker testing for solid tumors. Dr. Mehta’s expertise extends to guest speaking engagements, where he adeptly addresses audiences of pathologists and medical oncologists, sharing insights on both solid and liquid tumor management.

© 2024 Uhapo Health Services (P) Ltd.